Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
European Heart Journal|June 3, 2021
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF studyEwa A Jankowska, Bridget-Anne Kirwan, Mikhail Kosiborod, et al.
Lancet (London, England)|November 16, 2020
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trialPiotr Ponikowski, Bridget-Anne Kirwan, Stefan D Anker, et al.
The New England Journal of Medicine|September 3, 2019
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionScott D Solomon, John J V McMurray, Inder S Anand, et al.
JACC. Heart Failure|March 4, 2022
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER TrialScott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
International Journal of Cardiology|June 3, 2017
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapyGerhard Pölzl, Johann Altenberger, Loant Baholli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 9, 2020
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illnessManuel Rubio-Rivas, Mar Ronda, Ariadna Padulles, et al.
Journal of Cardiovascular Pharmacology|July 9, 2020
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
The New England Journal of Medicine|August 26, 2022
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D Solomon, John J V McMurray, Brian Claggett, et al.
Cardiac Failure Review|July 28, 2020
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
European Journal of Heart Failure|May 11, 2024
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialScott D Solomon, John W Ostrominski, Muthiah Vaduganathan, et al.
Pageof 15